Hello,

We are reviewing our processes for patients’ Schedule 1 items, oftentimes found in a patient’s belongings when they are admitted through the ED. Would be interested to hear how your institution stores or disposes of these items.
1. Are they bagged as patient’s valuables?
2. Stored with the House Supervisor, Security, Pharmacy, elsewhere?
3. Are they somehow discarded?
4. Are they returned to the patient at discharge?
5. Are they given to local law enforcement? If so, how is this process organized?

Thank you,

Renu Bajwa, Pharm.D.

Was a BCMSS program ever created, or is the ASHP’s Medication Safety Certificate Program the closest thing to a board certification we have available?

I'm inquiring on how other institutions organize their restricted medications in their policies or guidelines. What methods are used to list restrictions (i.e. meds that can only be administered on specific units) as a standard resource for the front line staff? Also, if in a policy, how many pages is the policy and are you willing to share?

Good morning - we are currently reviewing our practices with phenytoin IV administration. We offer opportunities to order both as IV push and IVPB and would like to move away from IV push. We, however, are finding information regarding final dilution of phenytoin to be no less than 5mg/mL, which would mean dilution of a typical 100mg in only 20cc. I am, however, not finding information on what the implications of further dilution in 50 or 100mL would be. Appreciate if others can share their phenytoin IV practices and dilutions.

For 2020/2021, we have decided to do a quarterly ADC Gap analysis with specific goals/benchmarks against all sites in the system and alignment with the ISMP gap analysis.

What is your process for securely resetting a password? If by telephone, what identifiers do you require to ensure that this is actually the person?

What does your health-system or facility do to help identify usage if a unit/floor is closed?

Thank you in advance,

Good morning all - reaching out to see if any hospitals have evaluated diltiazem IV use and implemented any strategies in preventing use for patients with heart failure. We will be undertaking a medication use evaluation in the near future but this has already been identified as an area for potential action.

I see there have been other posts on this topic, but none recently, at least none that describe this scenario, so I'm hoping you can help. I'm posting from Prince Edward Island, Canada, so there may be somewhat different standards in the US, but we don't have very many CPOE Cerner sites in Canada, so I wanted to reach out on here. We use Cerner, and have CPOE, we are also a relatively small hospital, and don't have clinical pharmacists on the floor in most areas. We don't use traditional automatic stop orders.

Does anyone have any policies on the use of medication samples in primary care? The use of samples is generally discouraged in our facility however we are hoping to develop our own policy to give staff some direction on what to do when these situations arise.

Has anyone had an increase of infusion related reactions or adverse effects from a 30 minute infusion?

We are infusing remdesivir over 120 min. We are now re-evaluating the 30 or 60 minute options.

Thank you in advance for your feedback!

Good Afternoon, we are in process of writing a medical marijuana policy and are looking for guidance from other hospitals that may have policies and workflows already in place. Also, how is medical marijuana capture on the EMR? What are the roles of the physician, pharmacist and nurse?

Thank you,
Kristen Post
Kristen.post@nicklaushealth.org
Risk Manager
Medication Safety